Xylem Inc. (LON:0M29)
London · Delayed Price · Currency is GBP · Price in USD 143.82
+1.92 (1.35%)
At close: Aug 4, 2025
Accolade Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 8,730 | 8,562 | 7,364 | 5,522 | 5,195 | 4,876 | Upgrade | |
Revenue Growth (YoY) | 3.98% | 16.27% | 33.36% | 6.30% | 6.54% | -7.11% | Upgrade |
Cost of Revenue | 5,429 | 5,350 | 4,647 | 3,438 | 3,220 | 3,046 | Upgrade |
Gross Profit | 3,301 | 3,212 | 2,717 | 2,084 | 1,975 | 1,830 | Upgrade |
Selling, General & Admin | 1,865 | 1,861 | 1,623 | 1,227 | 1,193 | 1,158 | Upgrade |
Research & Development | 227 | 230 | 232 | 206 | 204 | 187 | Upgrade |
Operating Expenses | 2,092 | 2,091 | 1,855 | 1,433 | 1,397 | 1,345 | Upgrade |
Operating Income | 1,209 | 1,121 | 862 | 651 | 578 | 485 | Upgrade |
Interest Expense | -36 | -44 | -49 | -50 | -76 | -77 | Upgrade |
Interest & Investment Income | 28 | 28 | 28 | 16 | 7 | 7 | Upgrade |
Earnings From Equity Investments | -4 | -4 | - | - | 9 | 2 | Upgrade |
Other Non Operating Income (Expenses) | -11 | -8 | 5 | -9 | -2 | 1 | Upgrade |
EBT Excluding Unusual Items | 1,186 | 1,093 | 846 | 608 | 516 | 418 | Upgrade |
Merger & Restructuring Charges | -112 | -105 | -206 | -15 | -6 | -54 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -58 | Upgrade |
Gain (Loss) on Sale of Investments | 152 | 152 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -52 | -46 | -1 | 1 | 2 | - | Upgrade |
Asset Writedown | -14 | -7 | -4 | -14 | -1 | -21 | Upgrade |
Other Unusual Items | - | - | - | -140 | - | - | Upgrade |
Pretax Income | 1,160 | 1,087 | 635 | 440 | 511 | 285 | Upgrade |
Income Tax Expense | 226 | 197 | 26 | 85 | 84 | 31 | Upgrade |
Earnings From Continuing Operations | 934 | 890 | 609 | 355 | 427 | 254 | Upgrade |
Minority Interest in Earnings | 4 | - | - | - | - | - | Upgrade |
Net Income | 938 | 890 | 609 | 355 | 427 | 254 | Upgrade |
Net Income to Common | 938 | 890 | 609 | 355 | 427 | 254 | Upgrade |
Net Income Growth | 22.61% | 46.14% | 71.55% | -16.86% | 68.11% | -36.66% | Upgrade |
Shares Outstanding (Basic) | 243 | 243 | 217 | 180 | 180 | 180 | Upgrade |
Shares Outstanding (Diluted) | 244 | 244 | 218 | 181 | 182 | 181 | Upgrade |
Shares Change (YoY) | 0.39% | 11.62% | 20.55% | -0.30% | 0.24% | -0.05% | Upgrade |
EPS (Basic) | 3.86 | 3.67 | 2.81 | 1.97 | 2.37 | 1.41 | Upgrade |
EPS (Diluted) | 3.84 | 3.65 | 2.79 | 1.96 | 2.35 | 1.40 | Upgrade |
EPS Growth | 21.62% | 30.82% | 42.35% | -16.60% | 67.86% | -36.65% | Upgrade |
Free Cash Flow | 844 | 942 | 566 | 388 | 330 | 641 | Upgrade |
Free Cash Flow Per Share | 3.46 | 3.87 | 2.59 | 2.14 | 1.82 | 3.54 | Upgrade |
Dividend Per Share | 1.520 | 1.440 | 1.320 | 1.200 | 1.120 | 1.040 | Upgrade |
Dividend Growth | 10.14% | 9.09% | 10.00% | 7.14% | 7.69% | 8.33% | Upgrade |
Gross Margin | 37.81% | 37.52% | 36.90% | 37.74% | 38.02% | 37.53% | Upgrade |
Operating Margin | 13.85% | 13.09% | 11.71% | 11.79% | 11.13% | 9.95% | Upgrade |
Profit Margin | 10.75% | 10.39% | 8.27% | 6.43% | 8.22% | 5.21% | Upgrade |
Free Cash Flow Margin | 9.67% | 11.00% | 7.69% | 7.03% | 6.35% | 13.15% | Upgrade |
EBITDA | 1,782 | 1,683 | 1,298 | 890 | 824 | 736 | Upgrade |
EBITDA Margin | 20.41% | 19.66% | 17.63% | 16.12% | 15.86% | 15.09% | Upgrade |
D&A For EBITDA | 573 | 562 | 436 | 239 | 246 | 251 | Upgrade |
EBIT | 1,209 | 1,121 | 862 | 651 | 578 | 485 | Upgrade |
EBIT Margin | 13.85% | 13.09% | 11.71% | 11.79% | 11.13% | 9.95% | Upgrade |
Effective Tax Rate | 19.48% | 18.12% | 4.09% | 19.32% | 16.44% | 10.88% | Upgrade |
Revenue as Reported | 8,730 | 8,562 | 7,364 | 5,522 | 5,195 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.